Vital KSK Holdings, Inc. (TYO:3151)

Vital KSK Holdings Financials Overview

Financials in millions JPY. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	620,069	610,497	600,370	587,481	579,772	577,249
Revenue Growth	2.74%	1.69%	2.19%	1.33%	0.44%	7.49%
Gross Profit Gross Profit Growth	50,094	49,582	49,215	48,302	44,963	43,977
Operating Income Operating Income Growth	2,912	4,029	5,707	5,454	2,471	2,947
Net Income Net Income Growth	2,856	7,362	7,308	5,843	4,831	4,770
Earnings Per Share EPS Growth	59.26	152.28	149.01	115.02	92.69	87.88
EPS Growth	-70.92%	2.20%	29.55%	24.09%	5.48%	313.55%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Unallocated Adjustment Unallocated Adjustment Growth	-13,923	-13,823	-13,534	-13,243	-13,015	-11,317
Nursing Care-related Rental and Other Business Nursing Care-related Rental and Other Business Growth	8,529	7,867	7,317	7,125	7,026	6,704
Veterinary Drug Wholesale Business Veterinary Drug Wholesale Business Growth	12,529	12,627	11,626	11,027	10,879	10,399
Pharmaceutical Wholesale Business Pharmaceutical Wholesale Business Growth	592,980	583,852	575,396	563,444	556,511	553,061
Pharmacy Business Pharmacy Business Growth	-	19,972	19,564	19,127	18,371	18,401
Total Total Growth	620,068	610,495	600,369	587,480	579,772	577,248

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	21,024	22,953	23,099	34,712	19,029	26,971
Total Debt Total Debt Growth	8,742	6,779	7,699	9,114	10,248	11,849
Net Cash (Debt) Net Cash Growth	12,282	16,174	15,400	25,598	8,781	15,122
Net Cash Growth	-29.84%	5.03%	-39.84%	191.52%	-41.93%	16.44%
Net Cash Per Share Net Cash Per Share Growth	254.83	334.56	314.00	503.92	168.48	278.59

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	2,158	4,833	-8,024	23,570	-3,001	7,487
Capital Expenditures CapEx Growth	-5,333	-3,722	-2,563	-1,845	-5,840	-3,415
Free Cash Flow Free Cash Flow Growth	-3,175	1,111	-10,587	21,725	-8,841	4,072
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	8.08%	8.12%	8.20%	8.22%	7.75%	7.62%
Operating Margin	0.47%	0.66%	0.95%	0.93%	0.43%	0.51%
Pretax Margin	0.86%	1.88%	1.78%	1.48%	1.40%	1.32%
Profit Margin	0.46%	1.21%	1.22%	1.00%	0.83%	0.83%
FCF Margin	-0.51%	0.18%	-1.76%	3.70%	-1.52%	0.70%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	70.000	70.000	45.000	42.000	39.000	24.000
Dividend Per Share Growth	0%	55.56%	7.14%	7.69%	62.50%	100.00%
Dividend Yield	4.91%	4.78%	3.58%	3.34%	4.36%	3.26%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	24.08	9.63	8.31	10.79	9.58	8.24
Forward PE	-	15.45	15.45	15.45	15.45	15.45
P/FCF Ratio	-	63.79	-	2.90	-	9.65
PS Ratio	0.11	0.12	0.10	0.11	0.08	0.07

Data Source: S&P Global Market Intelligence Last updated: Nov 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error